ArticlePloS one2015

Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells.

Rikio Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.